Skip to main content
Premium Trial:

Request an Annual Quote

Bulldog, BioCellChallenge Partner to Distribute Molecular Delivery Reagents

NEW YORK (GenomeWeb News) – Bulldog Bio will distribute BioCellChallenge's entire line of molecular delivery reagents in the US under a deal announced today.

Products covered by the deal include BioCellChallenge's novel chemistries for DNA and SiRNA transfection experiments and reagents for transporting proteins directly into cells.

Financial and other terms were not disclosed.

BioCellChallenge's reagents "offer a completely new approach to introducing plasmid, siRNAs and proteins into the cytoplasm and nucleus of cells," Ella Fontaine, vice president of communications for Bulldog Bio, said in a statement. "We're particularly excited about the encouraging results seen with primary and stem cells."

Bulldog Bio distributes tools to life science researchers and is based in Portsmouth, NH. BioCellChallenge is headquartered in France and is a privately held biotechnology firm specializing in drug delivery systems.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.